About this trial
This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered for inclusion. Subjects able to give consent are included.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
alcoholic liver disease able to consent
Disqualifiers
without alcoholic liver disease unable to consent
Trial population
subjects with alcoholic liver disease
Trial design
Cohort
Prospective
Treatments tested in this trial
survey
Other interventionsurveys will be administered at inclusion and follow-ups
Treatment groups
Trial outcomes
Primary outcomes
alcohol recidivism assessed by questionnaire
Follow-up questionnaires will be administered at 6 months assessing for alcohol use
alcohol recidivism assessed by clinical interview
Follow-up interviews will be conducted at 6 months assessing for alcohol use
alcohol recidivism assessed by urine ethyl glucuronide
Follow-up urine testing may be conducted at 6 months assessing for alcohol use
alcohol recidivism assessed by blood
Follow-up blood testing may be conducted at 6 months assessing for alcohol use
Secondary outcomes
alcohol recidivism assessed by questionnaire
Follow-up questionnaires will be administered after 6 months assessing for alcohol use
alcohol recidivism assessed by clinical interview
Follow-up clinical interviews will be conducted after 6 months assessing for alcohol use
alcohol recidivism assessed by urine ethyl glucuronide
Follow-up urine testing may be conducted after 6 months assessing for alcohol use
alcohol recidivism assessed by blood
Follow-up blood testing may be conducted after 6 months assessing for alcohol use
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Nicole T Shen
Lead sponsor
New York Presbyterian Hospital
Sponsor institution